» Articles » PMID: 32180558

Mechanisms of Insulin Resistance Related to White, Beige, and Brown Adipocytes

Overview
Journal Mol Metab
Specialty Cell Biology
Date 2020 Mar 18
PMID 32180558
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The diminished glucose lowering effect of insulin in obesity, called "insulin resistance," is associated with glucose intolerance, type 2 diabetes, and other serious maladies. Many publications on this topic have suggested numerous hypotheses on the molecular and cellular disruptions that contribute to the syndrome. However, significant uncertainty remains on the mechanisms of its initiation and long-term maintenance.

Scope Of Review: To simplify insulin resistance analysis, this review focuses on the unifying concept that adipose tissue is a central regulator of systemic glucose homeostasis by controlling liver and skeletal muscle metabolism. Key aspects of adipose function related to insulin resistance reviewed are: 1) the modes by which specific adipose tissues control hepatic glucose output and systemic glucose disposal, 2) recently acquired understanding of the underlying mechanisms of these modes of regulation, and 3) the steps in these pathways adversely affected by obesity that cause insulin resistance.

Major Conclusions: Adipocyte heterogeneity is required to mediate the multiple pathways that control systemic glucose tolerance. White adipocytes specialize in sequestering triglycerides away from the liver, muscle, and other tissues to limit toxicity. In contrast, brown/beige adipocytes are very active in directly taking up glucose in response to β adrenergic signaling and insulin and enhancing energy expenditure. Nonetheless, white, beige, and brown adipocytes all share the common feature of secreting factors and possibly exosomes that act on distant tissues to control glucose homeostasis. Obesity exerts deleterious effects on each of these adipocyte functions to cause insulin resistance.

Citing Articles

Association Between Body Mass Index and Glycemic Control in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Deng L, Jia L, Wu X, Cheng M Diabetes Metab Syndr Obes. 2025; 18:555-563.

PMID: 40007519 PMC: 11853989. DOI: 10.2147/DMSO.S508365.


Positive Evolution of a Child Suffering from Caudal Regression Syndrome and Agenesia Sacra After Treatment with Growth Hormone and Rehabilitation.

Devesa J, Fresco C, Devesa A, Rodriguez A, de Souza D Int J Mol Sci. 2025; 26(4).

PMID: 40004100 PMC: 11855933. DOI: 10.3390/ijms26041627.


Association between triglyceride‑glucose index as a marker of insulin resistance and the risk of malignant melanoma: A retrospective study.

Sun J, Han Z, Song C Oncol Lett. 2025; 29(4):173.

PMID: 39968015 PMC: 11834148. DOI: 10.3892/ol.2025.14919.


Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications.

Mlynarska E, Czarnik W, Dzieza N, Jedraszak W, Majchrowicz G, Prusinowski F Int J Mol Sci. 2025; 26(3).

PMID: 39940862 PMC: 11817707. DOI: 10.3390/ijms26031094.


Divergent roles of mA in orchestrating brown and white adipocyte transcriptomes and systemic metabolism.

Xiao L, De Jesus D, Ju C, Wei J, Hu J, DiStefano-Forti A Nat Commun. 2025; 16(1):533.

PMID: 39788955 PMC: 11718074. DOI: 10.1038/s41467-024-55694-w.


References
1.
Jespersen N, Feizi A, Andersen E, Heywood S, Hattel H, Daugaard S . Heterogeneity in the perirenal region of humans suggests presence of dormant brown adipose tissue that contains brown fat precursor cells. Mol Metab. 2019; 24:30-43. PMC: 6531810. DOI: 10.1016/j.molmet.2019.03.005. View

2.
Hepler C, Shan B, Zhang Q, Henry G, Shao M, Vishvanath L . Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice. Elife. 2018; 7. PMC: 6167054. DOI: 10.7554/eLife.39636. View

3.
Sharp L, Shinoda K, Ohno H, Scheel D, Tomoda E, Ruiz L . Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One. 2012; 7(11):e49452. PMC: 3500293. DOI: 10.1371/journal.pone.0049452. View

4.
Poher A, Altirriba J, Veyrat-Durebex C, Rohner-Jeanrenaud F . Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance. Front Physiol. 2015; 6:4. PMC: 4311629. DOI: 10.3389/fphys.2015.00004. View

5.
Sacks H, Fain J, Bahouth S, Ojha S, Frontini A, Budge H . Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab. 2013; 98(9):E1448-55. DOI: 10.1210/jc.2013-1265. View